Business description: BIGN HLDG

Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.

Number of employees: 495

Sales by Activity: BIGN HLDG

Fiscal Period: June20192020202120222023

Internet Software & Services

19.88M 31.01M 43.87M 108M 122M
See all business segments

Geographical breakdown of sales: BIGN HLDG

Fiscal Period: June20192020202120222023

United States of America

16.47M 28.19M 39.14M 93.54M 102M

Rest of The World

2.12M 1.03M 3.18M 10.27M 14.77M


1.29M 1.78M 1.55M 4.22M 5.67M
See all geographic segments

Managers: BIGN HLDG

Insider TitleAgeSince
Founder - 31/12/10
President - 31/12/11
Chief Operating Officer - 31/10/14
Corporate Officer/Principal - 04/04/18
See BIGN HLDG governance

Members of the board: BIGN HLDG

Insider TitleAgeSince
Chairman - 27/09/16
Founder - 31/12/10
Director/Board Member - 27/09/16
Composition of the Board of Directors

Shareholders: BIGN HLDG

Regal Funds Management Pty Ltd.
13.87 %
113,999,655 13.87 % 8 M $
Australian Ethical Investments Ltd. (Investment Management)
10.03 %
82,398,877 10.03 % 6 M $
SQN Investors LP
9.822 %
80,704,740 9.822 % 5 M $
MA Investment Management Pty Ltd.
3.613 %
29,683,410 3.613 % 2 M $
15,311,197 1.863 % 1 M $
List of BIGN HLDG shareholders

Company details: BIGN HLDG

BigTinCan Holdings Ltd.

338 Pitt Street Level 6

2000, Sydney

address BIGN HLDG(BTH)


This company's sector is not yet available
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target

Annual profits - Rate of surprise